Ameliorative Effect of Linalool in Cisplatin-Induced Nephrotoxicity: The Role of HMGB1/TLR4/NF-κB and Nrf2/HO1 Pathways

Biomolecules. 2020 Oct 28;10(11):1488. doi: 10.3390/biom10111488.

Abstract

Background: The monoterpene linalool is a well-known essential oil component produced by several aromatic plants. Cisplatin is a widely used anticancer drug that produces many side effects, particularly nephrotoxicity. Here, we aimed to inspect linalool's protective activity against cisplatin-induced nephrotoxicity and explore part of the underlying mechanisms.

Methods: Male Wistar rats were given linalool (50 and 100 mg/kg/day orally) for 15 days; then challenged with cisplatin (8 mg/kg) on the 12th day. Renal function parameters, oxidative stress, inflammatory and apoptotic markers, and toll-like receptor pathway gene, and protein expressions were investigated. Histopathology, immunohistochemistry, and cell-line mediated cytotoxicity assays were conducted.

Results: Linalool ameliorated kidney function after cisplatin challenge and managed all oxidation system parameters including GSH, SOD, CAT, MDA, NADPH, and particularly the Nrf2-mediated pathway markers. Linalool decreased TLR4, MYD88 and TRIF gene and protein expressions; diminished related inflammatory mediators such as TNF-α, IL-1β, IL-6, and NF-κB; and down-regulated HMBG1. Linalool mitigated cisplatin-induced apoptotic markers such as caspase 3, caspase 9, and Bax expression, and boosted the anti-apoptotic Bcl2 expression. Linalool potentiated the cytotoxic effect of cisplatin when investigated on HeLa and PC3 human cancer cell lines.

Conclusion: Linalool could protect against cisplatin-induced kidney function and tissue damage.

Keywords: apoptosis; essential oil; human cell line cytotoxicity; monoterpenes; oxidative stress; toll-like receptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acyclic Monoterpenes / administration & dosage
  • Acyclic Monoterpenes / chemistry
  • Acyclic Monoterpenes / pharmacology*
  • Administration, Oral
  • Animals
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cisplatin / antagonists & inhibitors*
  • Cisplatin / pharmacology
  • Dose-Response Relationship, Drug
  • Drug Screening Assays, Antitumor
  • HMGB1 Protein / antagonists & inhibitors
  • HMGB1 Protein / metabolism
  • Humans
  • Kidney / drug effects*
  • Kidney / metabolism
  • Male
  • Molecular Conformation
  • NF-E2-Related Factor 2 / antagonists & inhibitors
  • NF-E2-Related Factor 2 / metabolism
  • NF-kappa B / antagonists & inhibitors
  • NF-kappa B / metabolism
  • Oxidative Stress / drug effects
  • Rats
  • Rats, Wistar
  • Toll-Like Receptor 4 / antagonists & inhibitors
  • Toll-Like Receptor 4 / metabolism

Substances

  • Acyclic Monoterpenes
  • Antineoplastic Agents
  • HMGB1 Protein
  • Hbp1 protein, rat
  • NF-E2-Related Factor 2
  • NF-kappa B
  • Nfe2l2 protein, rat
  • Tlr4 protein, rat
  • Toll-Like Receptor 4
  • linalool
  • Cisplatin